HEGGIE THERESA
SEC insider (Form 3/4/5 filer). CIK 0001760020. Director at BIOCRYST PHARMACEUTICALS INC (BCRX) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in DURHAM, NC.
Companies HEGGIE THERESA has filed insider reports for
- BIOCRYST PHARMACEUTICALS INC (BCRX): Director
- ProQR Therapeutics N.V. (PRQR): Director
HEGGIE THERESA
CIK: 0001760020
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 11, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
AwardDirect15.3K shares- - Mar 20, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
ExerciseDirect49.9K shares at avg. $6.30$315K - Mar 20, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
SaleDirect49.9K shares at avg. $10.11$505K - Aug 13, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
ExerciseDirect40K shares at avg. $5.41$216K - Aug 13, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
SaleDirect70K shares at avg. $8.51$596K - Aug 13, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
ExerciseDirect30K shares at avg. $2.91$87K - Jun 12, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
AwardDirect12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  BCRX BIOCRYST PHARMACEUTICALS INC | Award | 15,294 | - | $0 | Direct |
| Mar 20, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Exercise | 49,933 | $6.30 | $314,578 | Direct |
| Mar 20, 2026 | BCRX BIOCRYST PHARMACEUTICALS INC | Sale | 49,933 | $10.11 | $504,823 | Direct |
| Aug 13, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Exercise | 40,000 | $5.41 | $216,400 | Direct |
| Aug 13, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Sale | 70,000 | $8.51 | $595,868 | Direct |
| Aug 13, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Exercise | 30,000 | $2.91 | $87,300 | Direct |
| Jun 12, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award | 12,500 | - | - | Direct |
1-7 of 7 transactions